“…[18][19][20] The beneficial effect of MV has been particularly good for girls. 3,4,16,20 However, these results have not had any consequences for the immunization program in terms of assessing the optimal age of measles immunization, the number or doses or the impact of measles immunization on child survival. On the assumption that RCT will be more convincing, we tested the effect of providing MV at 4.5 months of age in addition to the usual MV at nine months of age in a large randomized trial.…”